cobas Cdiff Test
by Roche Molecular Systems, Inc.
510(k) K142422
cobas Cdiff Test is a medical device (FDA Class II; FDA product code OZN, C. Difficile Toxin Gene Amplification Assay) made by Roche Molecular Systems, Inc., cleared under FDA 510(k) K142422 on 20 May 2015, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK142422 | Date20 May 2015 | StatusActive |
Official records
- FDA 510(k) database K142422
From the FDA record
- Received by the FDA
- 28 Aug 2014
- FDA decision
- 20 May 2015 (Substantially Equivalent)
- FDA review time
- 265 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- OZN
- Device class
- Class II
- Regulation
- 21 CFR Part 866.3130
- Advisory committee
- Microbiology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code OZN (C. Difficile Toxin Gene Amplification Assay).
- Simplexa™ C. difficile Direct MOL2950 by DiaSorin Molecular LLC
- Great Basin Toxigenic C. difficile Direct Test (CDF2) by Vela Operations USA
- BD MAX™ System 441916 by Becton, Dickinson and Company
- QUIDEL MOLECULAR DIRECT C. DIFFICILE ASSAY by Quidel Corp.
- GenePOC CDiff by Genepoc, Inc.
- Xpert C. difficile/Epi by CEPHEID
- ICEPLEX C. DIFFICILE ASSAY KIT, ICEPLEX SYSTEM by Primeradx
- Lyra Direct C. difficile Assay M105 by Quidel Corp.
- IMDX C.DIFFICILE FOR ABBOTT M2000 by Intelligent Medical Devices, Inc.
- ARIES C. difficile Assay Complete Kit, ARIES C. difficile Assay Protocol File Kit, ARIES C. difficile Assay Kit (24 cassettes), ARIES Stool Resuspension Kit by Luminex Corporation